 |
市場調查報告書
商品編碼
1397195
傳輸介質市場規模和份額分析（按產品類型、應用、適應症和最終用戶）：全球工業需求預測（截至 2030 年）Transport Media Market Size and Share Analysis by Product Type, Application, Indication, End User - Global Industry Demand Forecast to 2030 |
||||||
全球交通媒體市場規模預計到 2023 年將達到 31.013 億美元，到 2030 年將擴大到 42.106 億美元，複合年增長率為 4.6%。
該行業的成長是由與病毒性疾病相關的研究和開發的增加、對臨床前和診斷測試的需求不斷增長以及流感和皰疹等傳染病數量的快速增加所推動的。
例如，到 2022 年，全球約有 40 萬人將死於流感。 同樣，大約 40 億人患有皰疹。 此外，政府加大力度提高測試套件的接受度也推動了該產業的發展。
按產品類型劃分，病毒傳輸媒體類別將於 2023 年以 35% 的份額引領業界。 這可能是因為 COVID-19 和猴痘等傳染病的意外爆發增加了對感染者進行檢測和診斷的需求。
此外，在 COVID-19 大流行期間，人們對治療和診斷的認識不斷提高，從而增加了對檢測各種其他傳染病的相關產品的需求。
有跡象表明，病毒性疾病類別主導了傳輸介質市場。 此外，這個類別正以十年來最快的速度發展。 這主要是由於流感、猴痘、皰疹、COVID-19、呼吸道合胞病毒、水痘帶狀皰疹等病毒性疾病發生率急遽上升。
此外，在這些疾病中，流感和 COVID-19 病毒是傳染性最強的呼吸道疾病，因此引起了全世界的嚴重關注。
從最終用戶來看，診斷實驗室類別在產業中佔據最大份額。 這是由於對 COVID-19 的測試和診斷的需求增加。 這推動了診斷實驗室的建立並增加了工作量。
北美在該行業佔據主導地位。 這是由於診斷測試的激增、傳染病研究和開發的增加、醫療保健系統的建立以及大量製藥和生物技術公司的存在。
基本上，傳染病，尤其是病毒性疾病的激增，是幫助各公司創造收入的主要因素。
由於萊姆病、結核病和 COVID-19 等傳染病的盛行率不斷上升，亞太地區預計將在過去十年中以最快的複合年增長率增長。
此外，亞太地區（尤其是印度和中國）的傳染病患者數量非常多。 因此，多家公司紛紛介入，以滿足診斷上龐大的未滿足需求。
隨著病毒性疾病研究和開發的不斷增加以及傳染病發病率的上升，傳輸介質產業可能在未來幾年繼續發展。
目錄
第一章分析範圍
第二章分析方法
第 3 章執行摘要
第 4 章市場指標
第五章產業展望
- 市場動態
- 趨勢
- 促進因素
- 抑制因素/挑戰
- 促進/抑制因子影響分析
- 新型冠狀病毒感染 (COVID-19) 的影響
- 波特五力分析
第六章世界市場
- 摘要
- 市場收入：依產品類型劃分（2017-2030 年）
- 市場收入：依應用分類（2017-2030 年）
- 市場收入：依指標分類（2017-2030 年）
- 市場收入：以最終用戶劃分（2017-2030 年）
- 市場收入：按地區劃分（2017-2030 年）
第七章北美市場
- 摘要
- 市場收入：依產品類型劃分（2017-2030 年）
- 市場收入：依應用分類（2017-2030 年）
- 市場收入：依指標分類（2017-2030 年）
- 市場收入：以最終用戶劃分（2017-2030 年）
- 市場收入：依國家/地區劃分（2017-2030 年）
第8章歐洲市場
第9章亞太市場
第十章中南美市場
第十一章中東非洲市場
第12章美國市場
- 摘要
- 市場收入：依產品類型劃分（2017-2030 年）
- 市場收入：依應用分類（2017-2030 年）
- 市場收入：依指標分類（2017-2030 年）
- 市場收入：以最終用戶劃分（2017-2030 年）
第十三章加拿大市場
第14章德國市場
第十五章法國市場
第十六章英國市場
第十七章義大利市場
第十八章西班牙市場
第十九章日本市場
第20章中國市場
第21章印度市場
第22章澳洲市場
第23章韓國市場
第24章巴西市場
第25章墨西哥市場
第26章沙烏地阿拉伯市場
第27章南非市場
第 28 章阿聯酋 (UAE) 市場
第29章競爭態勢
- 市場參與者及其產品列表
- 主要公司的競爭基準
- 各大公司的產品基準
- 近期策略發展狀況
第30章公司簡介
- Thermo Fisher Scientific Inc.
- Puritan Medical Products LLC
- Becton, Dickinson and Company
- COPAN Diagnostics Inc.
- Laboratory Corporation of America Holdings
- HiMedia Laboratories Pvt. Ltd.
- Trinity Biotech plc
- EKF Diagnostics Holdings plc
- Alpha Teknova Inc.
- Vircell S.L.
- Medical Wire & Equipment
- Lucence Health Inc.
- Merck KGaA
- Wuxi AppTec Co. Ltd.
- Bio-Rad Laboratories Inc.
第31章附錄
The transport media market is estimated to reach USD 3,101.3 million in 2023, which will increase to USD 4,210.6 million, with a 4.6% compound annual growth rate, by 2030.
The growth of this industry is because of the rising R&D on viral illnesses, increasing need for pre-clinical and diagnostic testing, and the surging occurrence of infectious ailments like influenza and herpes.
For example, in 2022, around 400,000 individuals died from influenza globally. Likewise, approximately 4 billion individuals have herpes. Moreover, the growing count of government initiatives to enhance the acceptance of testing kits is also boosting the industry.
The viral transport media category, based on product type, is leading the industry, with a 35% share, in 2023. This can be because of the unexpected outbreak of infectious ailments like COVID-19 and monkeypox, which boost the requirement for testing and diagnosis among the infected people.
Furthermore, the growing consciousness of treatment and diagnosis during the pandemic of COVID-19 has increased the requirement for related products for detecting various other infections.
The viral diseases category, on the basis of indication, is dominating the transport media market. Furthermore, the category will also advance at the fastest rate during this decade. This can be primarily because of the surging incidence of viral ailments like influenza, monkeypox, herpes, COVID-19, respiratory syncytial virus, and Varicella zoster.
Moreover, among these ailments, the influenza and COVID-19 virus are the most contagious respiratory ailments, therefore, they are a serious cause for worry globally.
The diagnostic laboratories category, based on end user, is the largest contributor to the industry. This is because of the increase in the need for testing as well as diagnosis of COVID-19. This has powered the formation of diagnostic labs and increased their workload.
North America is dominating the industry. This is because of the surging number of diagnostic tests, rising R&D on infectious ailments, well-established healthcare system, and the existence of numerous pharma and biotech businesses.
Basically, the surging occurrence of infectious illnesses, particularly viral ailments, is a main factor that assists in revenue generation for industry players.
APAC will advance at the fastest compound annual growth rate during this decade, because of the rising prevalence of infectious illnesses like Lyme disease, tuberculosis, and COVID-19.
Moreover, the number of people with infectious illnesses is quite high in APAC, particularly in India and China. Therefore, several industry players have arrived to satisfy the vast unmet necessity for diagnosis.
It is because of the increasing research & development in viral ailments and the mounting incidence of infectious illnesses, the transport media industry will continue to progress in the coming years.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product type
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by indication
- 1.4.4. Market size breakdown, by end user
- 1.4.5. Market size breakdown, by region
- 1.4.6. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product Type (2017-2030)
- 6.3. Market Revenue, by Application (2017-2030)
- 6.4. Market Revenue, by Indication (2017-2030)
- 6.5. Market Revenue, by End User (2017-2030)
- 6.6. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product Type (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by Indication (2017-2030)
- 7.5. Market Revenue, by End User (2017-2030)
- 7.6. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product Type (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by Indication (2017-2030)
- 8.5. Market Revenue, by End User (2017-2030)
- 8.6. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product Type (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by Indication (2017-2030)
- 9.5. Market Revenue, by End User (2017-2030)
- 9.6. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product Type (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by Indication (2017-2030)
- 10.5. Market Revenue, by End User (2017-2030)
- 10.6. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product Type (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by Indication (2017-2030)
- 11.5. Market Revenue, by End User (2017-2030)
- 11.6. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product Type (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.4. Market Revenue, by Indication (2017-2030)
- 12.5. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product Type (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.4. Market Revenue, by Indication (2017-2030)
- 13.5. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product Type (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.4. Market Revenue, by Indication (2017-2030)
- 14.5. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product Type (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.4. Market Revenue, by Indication (2017-2030)
- 15.5. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product Type (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.4. Market Revenue, by Indication (2017-2030)
- 16.5. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product Type (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.4. Market Revenue, by Indication (2017-2030)
- 17.5. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product Type (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.4. Market Revenue, by Indication (2017-2030)
- 18.5. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product Type (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.4. Market Revenue, by Indication (2017-2030)
- 19.5. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product Type (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.4. Market Revenue, by Indication (2017-2030)
- 20.5. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product Type (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.4. Market Revenue, by Indication (2017-2030)
- 21.5. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product Type (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.4. Market Revenue, by Indication (2017-2030)
- 22.5. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product Type (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.4. Market Revenue, by Indication (2017-2030)
- 23.5. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product Type (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.4. Market Revenue, by Indication (2017-2030)
- 24.5. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product Type (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.4. Market Revenue, by Indication (2017-2030)
- 25.5. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product Type (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.4. Market Revenue, by Indication (2017-2030)
- 26.5. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product Type (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.4. Market Revenue, by Indication (2017-2030)
- 27.5. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product Type (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.4. Market Revenue, by Indication (2017-2030)
- 28.5. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Thermo Fisher Scientific Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Puritan Medical Products LLC
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.3. Becton, Dickinson and Company
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. COPAN Diagnostics Inc.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.5. Laboratory Corporation of America Holdings
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. HiMedia Laboratories Pvt. Ltd.
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.7. Trinity Biotech plc
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. EKF Diagnostics Holdings plc
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. Alpha Teknova Inc.
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. Vircell S.L.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.11. Medical Wire & Equipment
- 30.11.1. Business overview
- 30.11.2. Product and service offerings
- 30.12. Lucence Health Inc.
- 30.12.1. Business overview
- 30.12.2. Product and service offerings
- 30.13. Merck KGaA
- 30.13.1. Business overview
- 30.13.2. Product and service offerings
- 30.13.3. Key financial summary
- 30.14. Wuxi AppTec Co. Ltd.
- 30.14.1. Business overview
- 30.14.2. Product and service offerings
- 30.14.3. Key financial summary
- 30.15. Bio-Rad Laboratories Inc.
- 30.15.1. Business overview
- 30.15.2. Product and service offerings
- 30.15.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
